Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease

Conclusion
A large proportion of contemporary CVD patients would be eligible for intensified antithrombotic treatment trials, with mostly similar adjusted event risks to ineligible patients. Trial-based guideline recommendations are largely applicable to real-world patients.

Source: Heart - March 12, 2024 Category: Cardiology Authors: Castelijns, M. C., Hageman, S. H. J., Teraa, M., van der Meer, M. G., Westerink, J., ten Berg, J., Visseren, F. L. J. Tags: Aortic and vascular disease Source Type: research